secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2026-07-31T20:15:35+00:00
Accession:  0001104659-26-089220
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------

- Nasdaq notified Traws Pharma on July 29, 2026, of non-compliance with minimum bid price rule.
- Company has 180 days, until January 25, 2027, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, Nasdaq may grant a second 180-day period if other listing standards are met.
- Company intends to monitor bid price and consider available options to regain compliance.
- Listing remains effective during the compliance period; failure could lead to delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926089220/0001104659-26-089220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926089220/tm2621656d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-089220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer